Klotrimazolas Polpharm (Clotrimazole)

Clotrimazole works by inhibiting the fungal enzyme lanosterol 14α‑demethylase, which is essential for the synthesis of ergosterol, a key component of fungal cell membranes. Disruption of ergosterol production weakens the membrane, leading to increased permeability, impaired growth, and ultimately fungal cell death.

The specific dosing regimen for Klotrimazolas Polpharm is determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and the product’s concentration. Typically, a thin layer is applied to the affected skin once or twice daily for the duration recommended by the prescriber.

Safety data for clotrimazole in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Klotrimazolas Polpharm with their physician. The prescriber will weigh potential benefits against any possible risks to the mother and infant.

To request Klotrimazolas Polpharm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then replies with pricing, availability, shipping details and any required import documentation.

Clotrimazole is an imidazole antifungal with a broad spectrum against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, clotrimazole generally has a similar efficacy for mild to moderate infections but may be less potent for certain resistant strains. Its safety profile is well‑established, and it is available over‑the‑counter in many markets.

Store Klotrimazolas Polpharm at room temperature, typically below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, heat and direct sunlight. Do not freeze the product. Ensure the container is kept out of reach of children.

Klotrimazolas Polpharm is applied topically. Clean and dry the affected skin area, then spread a thin layer of the cream or ointment over the lesion. Wash hands after application unless the hands are the treatment site. Follow the prescriber’s instructions regarding frequency and duration of use.

While most reactions are mild, serious adverse events can occur. These include allergic contact dermatitis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and angioedema. If any signs of severe skin reaction, swelling, blistering, or systemic symptoms develop, discontinue use immediately and seek medical attention.

Individuals with a known hypersensitivity to clotrimazole or any component of the formulation should avoid using Klotrimazolas Polpharm. It is also contraindicated on large areas of broken skin, in patients with extensive mucosal involvement, and in infants unless specifically directed by a healthcare professional.